Cassava Sciences' Alzheimer's drug simufilam failed its Phase 3 trial, causing the stock to plummet ~90% and trade near book value. The company's decision to discontinue other simufilam trials ...
Cassava Sciences' troubled development of Alzheimer's disease candidate simufilam looks like it may have finally reached the end. The Austin, Texas-based biotech revealed that simufilam failed its ...
Cassava is advancing simufilam through a pivotal phase 3 trial, despite lingering controversy from a SEC investigation. As the company prepares to release trial results, Ben Hargreaves finds that ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Deep-pocketed investors have adopted a bullish approach towards Cassava Sciences SAVA, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...
Regardless of how they perform at the Academy Awards, these two films belong among the best Netflix original movies right now. And you can find the rest of our picks below. Malcolm Washington ...
If you’re after Cake Off codes, we’ve got some fresh out of the oven for you. In this competitive Roblox baking game, you can create your dream confections and flex your skills by baking and ...